Welcome to the Kramer Lab! Learn more about us below.
Jill Kramer, DDS, PhD, directs an NIH-funded research program focused on autoimmune diseases with oral manifestations. Her research focuses on chronic inflammation that occurs in the context of Sjögren’s disease (SjD). SjD is a systemic autoimmune disease that often results in loss of saliva and tear production. Extra-glandular manifestations are also well-documented, as the kidneys, lungs, and nervous system are affected. Her group has identified several key pathways that mediate sex-biased, organ-specific SjD manifestations.
Dr. Kramer has served as president of the International Association for Dental Research Salivary Research Group, and she is an alumna of the American Dental Education Association Leadership Institute. She is a Diplomate of the American Board of Oral and Maxillofacial Pathology and a Fellow of the American Academy of Oral and Maxillofacial Pathology.
The Kramer Lab is interested in understanding how MyD88-mediated signaling contributes to inflammation in SjD. MyD88 is a signaling molecule that is employed by Toll-like Receptor (TLR) and IL-1 Receptor family members, and activation of these pathways is critical for immune responses. Currently, there are no curative therapies available for SjD. We are interested in studying these pathways to identify novel therapeutic targets that will improve the management of patients with this debilitating disease.
Our lab is interested in understanding how TLRs and IL-1-related cytokines, such as IL-36 family members, mediate SjD. Current/ongoing work in the lab focuses on:
Location: 520 Biomedical Research Building, Buffalo, NY 14214
Laboratory Phone Number: 716-829-2551

